BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9893193)

  • 1. Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen.
    Hartl A; Kiesslich J; Weiss R; Bernhaupt A; Mostböck S; Scheiblhofer S; Ebner C; Ferreira F; Thalhamer J
    J Allergy Clin Immunol; 1999 Jan; 103(1 Pt 1):107-13. PubMed ID: 9893193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoforms of the major allergen of birch pollen induce different immune responses after genetic immunization.
    Hartl A; Kiesslich J; Weiss R; Bernhaupt A; Mostböck S; Scheiblhofer S; Flöckner H; Sippl M; Ebner C; Ferreira F; Thalhamer J
    Int Arch Allergy Immunol; 1999 Sep; 120(1):17-29. PubMed ID: 10529585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of CpG motifs on a protein or DNA-based Th2-type immune response against major pollen allergens Bet v 1a, Phl p 2 and Escherichia coli-derived beta-galactosidase.
    Hochreiter R; Hartl A; Freund J; Valenta R; Ferreira F; Thalhamer J
    Int Arch Allergy Immunol; 2001; 124(1-3):406-10. PubMed ID: 11307030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oligodeoxynucleotides containing CpG motifs modulate the allergic TH2 response of BALB/c mice to Bet v 1, the major birch pollen allergen.
    Jahn-Schmid B; Wiedermann U; Bohle B; Repa A; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Nov; 104(5):1015-23. PubMed ID: 10550747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant bet v 1, the major birch pollen allergen, in a murine model of type I allergy.
    Wiedermann U; Jahn-Schmid B; Bohle B; Repa A; Renz H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1999 Jun; 103(6):1202-10. PubMed ID: 10359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of allergen-specific IgE production and suppression of an established Th2-type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch-pollen allergen.
    Hochreiter R; Stepanoska T; Ferreira F; Valenta R; Vrtala S; Thalhamer J; Hartl A
    Eur J Immunol; 2003 Jun; 33(6):1667-76. PubMed ID: 12778485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen.
    Bauer R; Himly M; Dedic A; Ferreira F; Thalhamer J; Hartl A
    Allergy; 2003 Oct; 58(10):1003-10. PubMed ID: 14510717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen allergen Bet v 1a.
    Hartl A; Hochreiter R; Stepanoska T; Ferreira F; Thalhamer J
    Allergy; 2004 Jan; 59(1):65-73. PubMed ID: 14674936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th1-inducing effect of immunostimulatory CpG motifs in DNA vaccines.
    Weiss R; Scheiblhofer S; Freund J; Ferreira F; Livey I; Thalhamer J
    Vaccine; 2002 Aug; 20(25-26):3148-54. PubMed ID: 12163266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1.
    Hochreiter R; Ferreira F; Thalhamer J; Hammerl P
    J Allergy Clin Immunol; 2003 Sep; 112(3):579-84. PubMed ID: 13679818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen.
    Wiedermann U; Jahn-Schmid B; Fritsch R; Bauer L; Renz H; Kraft D; Ebner C
    Clin Exp Immunol; 1998 Jan; 111(1):144-51. PubMed ID: 9472674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunostimulatory oligodeoxynucleotide induces TH1 immune response and inhibition of IgE antibody production to cedar pollen allergens in mice.
    Kohama Y; Akizuki O; Hagihara K; Yamada E; Yamamoto H
    J Allergy Clin Immunol; 1999 Dec; 104(6):1231-8. PubMed ID: 10589006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization.
    Raz E; Tighe H; Sato Y; Corr M; Dudler JA; Roman M; Swain SL; Spiegelberg HL; Carson DA
    Proc Natl Acad Sci U S A; 1996 May; 93(10):5141-5. PubMed ID: 8643542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene gun immunization with clinically relevant allergens aggravates allergen induced pathology and is contraindicated for allergen immunotherapy.
    Scheiblhofer S; Stoecklinger A; Gruber C; Hauser-Kronberger C; Alinger B; Hammerl P; Thalhamer J; Weiss R
    Mol Immunol; 2007 Mar; 44(8):1879-87. PubMed ID: 17070909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune responses to recombinant tree pollen allergens (Bet v I and Bet v II) in mice: construction of a live oral allergy vaccine.
    Vrtala S; Grote M; Ferreira F; Susani M; Stocker B; Kraft D; Valenta R
    Int Arch Allergy Immunol; 1995; 107(1-3):290-4. PubMed ID: 7613152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and antibody responses in birch-pollen-allergic patients treated with genetically modified derivatives of the major birch pollen allergen Bet v 1.
    Gafvelin G; Thunberg S; Kronqvist M; Grönlund H; Grönneberg R; Troye-Blomberg M; Akdis M; Fiebig H; Purohit A; Horak F; Reisinger J; Niederberger V; Akdis CA; Cromwell O; Pauli G; Valenta R; van Hage M
    Int Arch Allergy Immunol; 2005 Sep; 138(1):59-66. PubMed ID: 16103688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
    Hoflehner E; Hufnagl K; Schabussova I; Jasinska J; Hoffmann-Sommergruber K; Bohle B; Maizels RM; Wiedermann U
    PLoS One; 2012; 7(6):e39409. PubMed ID: 22768077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deviation of the allergic IgE to an IgG response by gene immunotherapy.
    Raz E; Spiegelberg HL
    Int Rev Immunol; 1999; 18(3):271-89. PubMed ID: 10614729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-displayed Bet mim 1, a mimotope of the major birch pollen allergen Bet v 1, induces B cell responses to the natural antigen using bystander T cell help.
    Schöll I; Wiedermann U; Förster-Waldl E; Ganglberger E; Baier K; Boltz-Nitulescu G; Scheiner O; Ebner C; Jensen-Jarolim E
    Clin Exp Allergy; 2002 Nov; 32(11):1583-8. PubMed ID: 12569978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.